Form Approved
OMB No. 0920-xxxx Exp. Date xx/xx/xxxx
Coalition Survey
Welcome to the 1017 Coalition Survey!
The CCC Coalition Survey is being conducted by Battelle at the request of the Centers for Disease Control and Prevention (CDC), Division of Cancer Prevention and Control (DCPC). The survey is part of a larger comprehensive evaluation of a pilot program (also known as the 1017 program) in which CDC awarded additional funds to 13 Comprehensive Cancer Control (CCC) programs to increase their focus on Policy, System, and Environmental (PSE) change strategies.
You have been asked to participate in this survey because of your membership in the PSE Workgroup working with the 1017 program in your state or tribe. This survey is expected to take 20 minutes to complete.
Please answer the survey questions to the best of your ability based on your personal knowledge and experience with the PSE Workgroup. If you would like to consult with other staff members on any of the question items, you may do so. You do not need to complete the survey in one sitting. Your survey answers are not final until you hit the “Submit” button.
An identification number will be assigned to your completed survey in order to link information for all members of the same PSE Workgroup. Additional data security procedures will be implemented to ensure that your answers are maintained in a secure manner and your responses are never linked to you personally. You may choose not to participate in this survey, or to terminate your involvement at any time, without any penalty to you or your program. Completion of the survey constitutes your consent to participate.
If you have any questions about this evaluation please contact Battelle’s study director Carlyn Orians at 206-528-3320, or CDC’s technical lead Angela Moore at 770-488-3094. If you have any questions about your rights as a research participant, please contact Chair, Battelle Institutional Review Board, at 1-877-810-9530, extension 500.
PROCEED TO SURVEY
Please select your organization/program/department from the list:
[List of all organizations that are members of the PSE Workgroup]
2. What is your job title?_____________________________
3. How long have you been in this position (in months)?_______________________
4. Please indicate what your organization contributes, or can potentially contribute, to the 1017 PSE Workgroup (Select as many as apply)
Funding
In-Kind resources (e.g., meeting space)
Paid staff
Volunteers and/or volunteer staff
Data resources including data sets, collection & analysis
Information/ feedback
Specific health expertise
Expertise in PSE change strategies
Expertise other than health or PSE change
Connections with community allies
Connection with community decision makers
Fiscal management (e.g. acting as fiscal agent)
Facilitation/leadership
Communication/ use of media to convey public health benefits of PSE change.
IT/web resources (e.g. server space, web site development, social media)
5. What is your organization's most important contribution to the 1017 PSE Workgroup? (Select one)
(Same response choices as in Q4)
6. Outcomes of the 1017 PSE Workgroup’s efforts include (or could potentially include): (Select as many as apply)
Improved communication/use of media
Public awareness
Community support
Decision maker’s understanding of the issue
Public policy changes
Health care system changes
Improved health outcomes
Community environmental changes
Reduction of health disparities
7. Which is the 1017 PSE Workgroup’s most important outcome? (Select one)
(Same response choices as in Q6)
8. How successful has 1017 PSE Workgroup been at reaching its goals? (Select one)
Not Successful
9. What aspects of collaboration contribute to this success? (Select as many as apply)
Bringing together diverse stakeholders
Meeting regularly
Exchanging information/knowledge
Sharing resources
Shared learning/technical assistance
Informal relationships created
Collective decision-making
Having a shared mission, goals
10. In your opinion, does your PSE Workgroup have sufficient representation from groups, organizations, and/or schools in your community to accomplish the objectives of the PSE Workgroup? (Select one).
No
Yes
Don’t know
11. There is general agreement with respect to the mission of the PSE Workgroup. (Select one)
Strongly Disagree
Disagree
Agree
Strongly Agree
Don’t Know
12. There is general agreement with respect to the priorities of the PSE Workgroup (Select one)
Strongly Disagree
Disagree
Agree
Strongly Agree
Don’t Know
13. There is general agreement with respect to the strategies the PSE Workgroup should use to pursue its priorities (Select one)
Strongly Disagree
Disagree
Agree
Strongly Agree
Don’t Know
14. I can talk openly and honestly at PSE Workgroup meetings. (Select one)
Strongly Disagree
Disagree
Agree
Strongly Agree
Don’t Know
15. I feel that I have a voice in what the PSE Workgroup decides. (Select one)
Strongly Disagree
Disagree
Agree
Strongly Agree
Don’t Know
16. Overall, how comfortable are you with decision-making processes within the PSE Workgroup? (Select one)
Not Comfortable
Somewhat Comfortable
Comfortable
Very Comfortable
Completely Comfortable
17. What are the main strategies your PSE Workgroup has used to address conflicts that occur? (Select two only)
Open debate about opposing viewpoints
Postponing or avoiding discussions of controversial issues
Having a third party mediate between those with opposing viewpoints
Having the opposing parties negotiate directly with each other
One party to the conflict gives in
Don’t know
18. From your organization’s perspective, how much do the benefits of participation in the PSE Workgroup outweigh the costs at this point? (Select one)
The costs outweigh the benefits
The benefits are roughly equal to the costs
The benefits outweigh the costs
Don’t know
19. From the list, select the organizations with which you have an established relationship (either formal or informal). You will be asked a set of questions about your relationship with each organization you select, in the context of the PSE Workgroup.
[List of all organizations that are members of the PSE Workgroup]
|
Question |
Partner 1 |
Partner 2 |
Partner 3… |
…Partner 20 |
Network Interaction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Strategic Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trust |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Power/Influence: The organization holds a prominent position in the community by being powerful, having influence, success as a change agent, and showing leadership.
**Level of Involvement: The organization is strongly committed and active in the partnership and gets things done.
***Contributing Resources: The organization brings resources to the partnership like funding, information, or other resources.
^Reliable: This organization is reliable in terms of following through on commitments.
^^Mission Congruence: this organization/program/department shares a common vision of the end goal of what working together should accomplish.
^^^Open to Discussion: This entity is willing to engage in frank, open and civil discussion (especially when disagreement exists). The entity is willing to consider a variety of viewpoints and talk together (rather than at each other). You are able to communicate with this entity in an open, trusting manner.
Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-xxxx).
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | CHOVNICKG |
File Modified | 0000-00-00 |
File Created | 2021-01-28 |